Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
10.51
+0.10 (0.96%)
At close: Mar 11, 2025, 4:00 PM
10.67
+0.16 (1.52%)
After-hours: Mar 11, 2025, 5:22 PM EST
Aligos Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -131.21 | -87.68 | -96.05 | -128.33 | -108.54 | |
| Depreciation & Amortization | 2.62 | 3.07 | 3.68 | 3.78 | 3.33 | |
| Loss (Gain) From Sale of Assets | - | 0.02 | - | - | - | |
| Asset Writedown & Restructuring Costs | - | 0.72 | - | - | - | |
| Loss (Gain) From Sale of Investments | -1.78 | -0.42 | -0.16 | 0.09 | 0.23 | |
| Stock-Based Compensation | 8.45 | 12.65 | 14.69 | 13.46 | 2.98 | |
| Other Operating Activities | 46.13 | 2.17 | - | - | 11.68 | |
| Change in Accounts Payable | 0.05 | -2.22 | 1.72 | -0.31 | -0.13 | |
| Change in Unearned Revenue | -1.16 | -8.14 | 2.5 | -4.36 | 12 | |
| Change in Other Net Operating Assets | -3.85 | 0.83 | -5.78 | 0.02 | 4.19 | |
| Operating Cash Flow | -80.74 | -79 | -79.39 | -115.66 | -74.26 | |
| Capital Expenditures | -0.13 | -0.02 | -0.94 | -0.89 | -2.06 | |
| Investment in Securities | -18.15 | 45 | -25.35 | 3.91 | 34.82 | |
| Investing Cash Flow | -18.28 | 44.98 | -26.29 | 3.02 | 32.76 | |
| Long-Term Debt Repaid | -0.08 | -0.1 | -0.06 | -0.08 | -0.06 | |
| Total Debt Repaid | -0.08 | -0.1 | -0.06 | -0.08 | -0.06 | |
| Net Debt Issued (Repaid) | -0.08 | -0.1 | -0.06 | -0.08 | -0.06 | |
| Issuance of Common Stock | 0.44 | 18.02 | 0.23 | 79.63 | 155.8 | |
| Other Financing Activities | - | 70.41 | - | -0.88 | -4.52 | |
| Financing Cash Flow | 0.36 | 88.33 | 0.16 | 78.68 | 192.35 | |
| Net Cash Flow | -98.67 | 54.31 | -105.52 | -33.96 | 150.84 | |
| Free Cash Flow | -80.87 | -79.02 | -80.33 | -116.55 | -76.33 | |
| Free Cash Flow Margin | -2050.01% | -508.83% | -577.64% | -2673.87% | - | |
| Free Cash Flow Per Share | -12.91 | -30.74 | -47.04 | -73.11 | -191.04 | |
| Levered Free Cash Flow | -55.44 | -45.91 | -43.65 | -62.76 | -44.6 | |
| Unlevered Free Cash Flow | -55.44 | -45.91 | -43.65 | -62.76 | -44.45 | |
| Change in Net Working Capital | 2.21 | 6.98 | 0.09 | -1.1 | -12.46 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.